Division of Surgery Gunma Children's Medical Center, Shibukawa, Gunma, Japan. RATIONALE: Sometimes, patients with eosinophilic gastroenteritis (EGE) have a remission without systemic steroids and/or elimination of foods. The aim of this study was to determine the characteristics of such patients with EGE successfully treated symptomatically with or without anti-allergic agents. METHODS: Symptoms, histological findings, and treatments of EGE patients treated without long-term systemic steroids and/or multiple-food elimination diets (MFED) in our hospital between 2012 and 2017 were retrospectively reviewed. EGE patients treated with MFED were used as controls. RESULTS: Six patients (two females) were included. The mean age at diagnosis was 9.3 years. Bloody stool and abdominal pain in 4 patients each and diarrhea, nausea, and weight loss in 1 patient each were observed as initial symptoms, respectively. Involved gastrointestinal tract portions were the duodenum and large intestine in 3 and 4 patients, respectively. The median number of peak gastrointestinal eosinophils showed 15-fold decrease after treatment. Two patients were successfully treated only with symptomatic treatment. Proton pump inhibitor was effective for 2 patients with duodenal ulcer. Anti-allergic agents induced remission in 3 patients. All 6 patients maintained remission; 3 still required continuous treatment. There were no significant differences in the number of gastrointestinal eosinophils and albumin and hemoglobin levels between these patients and EGE patients treated with MFED. CONCLUSIONS: These findings suggest that symptomatic treatment with or without anti-allergic agents can induce remission in patients with EGE and anti-allergic agents may be alternative long-term treatments for EGE. Oral Medicine Department, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. RATIONALE: Eosinophilic sialadenitis is newly described in the western world with a unique clinicopathologic entity, marked by recurrent salivary gland swelling and eosinophil-rich mucus plug or evidence of eosinophilic inflammation. This condition is mostly diagnosed in oral medicine department. As it is often associated with atopy, this cohort of patients have been recently referred to our allergy department for review. METHODS: There is limited experience as allergists in managing this condition. Retrospective case review was therefore undertaken to gain a better insight, in terms of its symptoms, investigations, diagnosis and managements. RESULTS: 6 patients (5 female; mean age 43) were seen from September 2017 to June 2018. Salivary gland and pruritus were reported in 100% and 'white stringy' substance noted in 50%. Sialogram documented ductal dilation in 100%. Eosinophilia of mucus plug was evident in 100%. Eosinophilic infiltration was noted in all 3 who had biopsy. Peripheral eosinophilia was noted in 33.3%. All were atopic of which 66.7% with raised IgE, 83.3% with positive skin prick test. IgG4 were sent in 5 with normal level in 80% and 20% with raised level (rheumatology referral advised). Complements were sent in 5 with normal level in 100%. None reported symptoms suggestive of eosinophilic esophagitis, hence esophageal biopsy was not suggested. Medical treatments with antihistamine and corticosteroid; surgical interventions with ductal dilatation and washout were beneficial in majority of cases. CONCLUSIONS: Allergists should be made aware of this condition. Larger studies are required to define its likely allergic etiology and determine the role of biologics as therapy. 500 University Drive, Penn State Hershey Medical Center, Hershey, PA. RATIONALE: While a genetic predisposition has been identified for EoE, studies have also suggested that early life exposures, such as diet, may play a role. Studies are mixed regarding the effect of breastfeeding, and little has been studied with regard to formula intake. METHODS: After IRB approval, patients with EoE seen in our Pediatric Allergy-Immunology clinic were identified. A retrospective chart review was done to collect demographic data, and a phone survey was completed by parents regarding dietary habits during infancy. RESULTS: The survey was completed by 48% (22/46) of patients. Of completed surveys, 82% (18/22) were male and 55% (12/22) were Caucasian. Average patient age at time of survey was 10.05 years. Average age of diagnosis was 7.18 years. Breastfeeding was initiated in 77% (17/22) of patients, with 50% reporting exclusive breastfeeding for any duration of time. 86% of patients (19/22) were formula fed, with 73% (16/22) of them receiving formula as the main source of nutrition once introduced. 58% (11/19) patients had received more than one type of formula and 6 (55%) of those patients currently avoid milk for anaphylaxis and/or EoE. CONCLUSIONS: Studies have not been conclusive regarding the role of breastfeeding in the development of EoE. While the number of patients who were breastfed nears national comparisons, many patients received formula as a primary source of nutrition during infancy. Formula intolerance, indicated by switching to a different formula protein source, was common. Milk-based formula intolerance may be an early indicator for the later development of EoE.
